Total Raised

$139.67M

Investors Count

13

Deal Terms

1

Funding, Valuation & Revenue

7 Fundings

Asceneuron has raised $139.67M over 7 rounds.

Asceneuron's latest funding round was a Series C for $100M on July 16, 2024.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/16/2024

Series C

$100M

$XXM

0

FY undefined

4

5/4/2022

Grant - III

$XXM

0

FY undefined

10

3/10/2021

Grant - II

$XXM

$XXM

0

FY undefined

10

10/6/2016

Grant

$XXM

0

FY undefined

10

9/29/2015

Series A

$XXM

$XXM

0

FY undefined

10

Date

7/16/2024

5/4/2022

3/10/2021

10/6/2016

9/29/2015

Round

Series C

Grant - III

Grant - II

Grant

Series A

Amount

$100M

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

4

10

10

10

10

Start free trial
New call-to-action

Asceneuron Deal Terms

1 Deal Term

Asceneuron's deal structure is available for 1 funding round, including their Series A from September 29, 2015.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

Asceneuron Investors

13 Investors

Asceneuron has 13 investors. M Ventures invested in Asceneuron's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/2/2012

7/16/2024

3
Seed VC, Series A (2015), Series C (2024)

Corporate Venture

Netherlands

9/29/2015

7/16/2024

2
Series A, Series C (2024)

Venture Capital

France

9/29/2015

7/16/2024

2
Series A, Series C (2024)

Venture Capital

Pennsylvania

00/00/0000

00/00/0000

Johnson & Johnson

Subscribe to see more

Corporation

New Jersey

00/00/0000

00/00/0000

Novo Holdings

Subscribe to see more

Holding Company

Denmark

First funding

10/2/2012

9/29/2015

9/29/2015

00/00/0000

00/00/0000

Last Funding

7/16/2024

7/16/2024

7/16/2024

00/00/0000

00/00/0000

Investor

Johnson & Johnson

Novo Holdings

Rounds

3
Seed VC, Series A (2015), Series C (2024)
2
Series A, Series C (2024)
2
Series A, Series C (2024)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporate Venture

Venture Capital

Venture Capital

Corporation

Holding Company

Location

Netherlands

France

Pennsylvania

New Jersey

Denmark

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.